缺血性卒中、颅内出血与代谢紊乱所致意识障碍患者UCH-L1水平研究
研究纳入80例缺血性卒中、40例颅内出血、80例代谢紊乱所致意识障碍患者及40名健康对照,检测血清UCH-L1水平。缺血性卒中组UCH-L1中位数5.59ng/mL、颅内出血组5.44ng/mL,均显著高于代谢紊乱组3.34ng/mL和健康对照组3.94ng/mL。ROC分析显示UCH-L1鉴别缺血性卒中的敏感度63.75%、特异度62.5%(AUC=0.626),鉴别颅内出血的敏感度75%、特异度55%(AUC=0.664),对代谢紊乱所致意识障碍无显著鉴别价值(AUC=0.525,p=0.6521)。UCH-L1水平随症状出现至采血时间延长而显著升高(r=0.345,p<0.001),但与年龄、GCS、mRS、NIHSS无相关性。
要点
- 缺血性卒中组UCH-L1中位数5.59ng/mL(IQR 3.90-9.37),颅内出血组5.44ng/mL(IQR 4.01-13.98),均显著高于代谢紊乱组3.34ng/mL(IQR 2.29-5.88)和健康对照组3.94ng/mL(IQR 3.31-7.95)。
- UCH-L1鉴别缺血性卒中的截断值4.336ng/mL,敏感度63.75%、特异度62.5%(AUC=0.626,95%CI 0.533-0.713,p<0.0199)。
- UCH-L1鉴别颅内出血的截断值4.036ng/mL,敏感度75%、特异度55%(AUC=0.664,95%CI 0.549-0.766,p<0.0071)。
- UCH-L1对代谢紊乱所致意识障碍的鉴别无统计学意义(截断值3.256ng/mL,敏感度36.25%、特异度77.5%,AUC=0.525,95%CI 0.432-0.617,p=0.6521)。
- UCH-L1水平随症状出现至采血时间延长而显著升高(r=0.345,p<0.001),与年龄、GCS、mRS、NIHSS无显著相关性。
适用人群与场景
- 因意识障碍就诊于急诊科的患者,包括缺血性卒中、颅内出血和代谢紊乱所致意识障碍;另设健康志愿者对照。
诊断标准与关键阈值
- UCH-L1鉴别缺血性卒中的截断值4.336ng/mL(敏感度63.75%、特异度62.5%,AUC=0.626,95%CI 0.533-0.713,p<0.0199)。
- UCH-L1鉴别颅内出血的截断值4.036ng/mL(敏感度75%、特异度55%,AUC=0.664,95%CI 0.549-0.766,p<0.0071)。
- UCH-L1鉴别代谢紊乱所致意识障碍的截断值3.256ng/mL(敏感度36.25%、特异度77.5%,AUC=0.525,95%CI 0.432-0.617,p=0.6521)。
研究设计与关键结果
- 研究纳入80例缺血性卒中、40例颅内出血、80例代谢紊乱所致意识障碍患者和40名健康对照,检测血清UCH-L1水平[中位数(IQR)]。
- UCH-L1水平:缺血性卒中5.59ng/mL(3.90-9.37),颅内出血5.44ng/mL(4.01-13.98),代谢紊乱所致意识障碍3.34ng/mL(2.29-5.88),健康志愿者3.94ng/mL(3.31-7.95);缺血性卒中和颅内出血组显著高于代谢紊乱组和健康对照组。
- ROC分析:缺血性卒中截断值4.336ng/mL,敏感度63.75%、特异度62.5%(AUC=0.626,p<0.0199,95%CI 0.533-0.713);颅内出血截断值4.036ng/mL,敏感度75%、特异度55%(AUC=0.664,p<0.0071,95%CI 0.549-0.766);代谢紊乱所致意识障碍截断值3.256ng/mL,敏感度36.25%、特异度77.5%(AUC=0.525,p=0.6521,95%CI 0.432-0.617)。
- UCH-L1水平随症状出现至采血时间延长而显著升高(r=0.345,p<0.001);与年龄(r=0.014,p=0.833)、GCS(r=-0.115,p=0.074)、mRS(r=0.063,p=0.475)、NIHSS(r=0.056,p=0.520)无显著相关性。
证据类型、等级与局限
- 证据类型:病例对照研究;局限:原文未报告局限性。
对床旁实践的改变
- 作者结论:缺血性卒中和颅内出血患者UCH-L1水平显著高于代谢紊乱所致意识障碍患者和健康志愿者;原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: We aimed to determine the levels of ubiquitin C-terminal hydrolase-L1 (UCH-L1) in patients admitted to the emergency department with impaired consciousness due to metabolic or neurological reasons.
MATERIALS - METHODS: The study included 80 patients with ischemic stroke (IS), 40 patients with intracranial hemorrhage (ICH), 80 patients with metabolic disorder induced impaired consciousness (MDIC) and 40 healthy controls.
RESULTS: The levels of UCH-L1 [median (IQR)] were as follows: 5.59ng/mL (3.90-9.37) in IS, 5.44ng/ml (4.01-13.98) in ICH, 3.34ng/ml (2.29-5.88) in MDIC and 3.94ng/ml (3.31-7.95) in healthy volunteers. Significantly higher levels were detected in IS and ICH than in MDIC and healthy volunteers. In ROC curve analysis, we detected 63.75% sensitivity and 62.5% specificity (AUC=0.626, p<0.0199, 95% CI: 0.533-0.713) with a cutoff value of 4.336ng/ml for IS and 75% sensitivity and 55% specificity (AUC=0.664, p<0.0071, 95% CI: 0.549-0.766) with a cut-off value of 4.036ng/ml for ICH. However, the sensitivity and specificity for MDIC was 36.25% and 77.5%, respectively, with a cut-off value of 3.256ng/ml (AUC=0.525, p=0.6521, 95% CI: 0.432-0.617). UCH-L1 levels were found to increase significantly with increasing time between the onset of symptoms and blood sampling (r=0.345, p<0.001). However, no correlation was found between UCH-L1 levels and age (r=0.014, p=0.833), GCS (r=-0.115, p=0.074), mRS (r=0.063, p=0.475) and NIHSS (r=0.056, p=0.520).
CONCLUSION: In this study, we detected significantly higher levels of UCH-L1 in patients with IS and ICH compared to patients with MDIC and healthy volunteers.
参考来源
- Yigit I, Atescelik M, Yilmaz M, et al. Investigation of UCH-L1 levels in ischemic stroke, intracranial hemorrhage and metabolic disorder induced impaired consciousness. Am J Emerg Med. 2017. PMID: 28651886. doi:10.1016/j.ajem.2017.06.032
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。